Bio-Techne CorporationTECHNASDAQ
Loading
TECH Revenue Growth (YoY Quarterly)•-0.39%
SAPRO
Growth Metrics
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.96% | +4.20% | +3.55% | -1.00% | -0.39% |
| Gross Profit Growth | +9.80% | +4.87% | -2.23% | +2.78% | -1.35% |
| EBITDA Growth | +10.06% | -26.57% | -91.10% | +6.78% | +7.71% |
| Operating Income Growth | +24.77% | -42.23% | -152.07% | +19.18% | +14.85% |
| Net Income Growth | +27.03% | -53.96% | -143.55% | +13.65% | +8.94% |
| EPS Growth | +29.41% | -54.84% | -142.31% | +19.05% | +9.09% |
| EPS Diluted Growth | +29.41% | -54.84% | -144.00% | +14.29% | +9.09% |
| Weighted Average Shares Growth | +0.57% | +0.04% | -1.87% | -1.93% | -1.64% |
| Weighted Average Shares Diluted Growth | +0.35% | -0.97% | -3.05% | -2.95% | -2.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +1.48% | -49.23% | +30.07% | -56.82% | -2.29% |
| Free Cash Flow Growth | +13.59% | -51.98% | +62.23% | -59.39% | -1.34% |
| Receivables Growth | +5.06% | +4.06% | -14.30% | -17.79% | -15.29% |
| Inventory Growth | +4.17% | +6.46% | +5.41% | +9.81% | +9.06% |
| Asset Growth | -2.21% | -2.83% | -5.40% | -7.67% | -5.53% |
| Book Value per Share Growth | +5.25% | +0.14% | -5.48% | -6.27% | -1.64% |
| Debt Growth | -28.90% | -14.40% | +5.84% | -1.11% | -11.19% |
| R&D Expense Growth | +9.16% | -4.59% | +8.52% | +1.56% | -7.56% |
| SG&A Expenses Growth | +5.00% | +35.25% | -61.61% | -2.47% | -6.39% |
1 / 4